Entecavir to treat hepatitis B-associated cryoglobulinemic vasculitis

Annals of Internal Medicine

Volumn 149, Issue 12, 2008, Pages 912-913

  Enomoto, Masaru ^a   Nakamishi, Takeshi ^a   Ishii, Masamitsu ^a   Tamori, Akihiro ^a   Kawada, Norifumi ^a  

^a Osaka Prefecture University   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CRYOGLOBULIN; ENTECAVIR; HEPATITIS B SURFACE ANTIGEN; VIRUS DNA;

ADULT; CASE REPORT; CLINICAL FEATURE; CRYOGLOBULINEMIC VASCULITIS; DISEASE ASSOCIATION; FEMALE; GENOTYPE; HEPATITIS B; HUMAN; HUMAN TISSUE; LETTER; LIVER BIOPSY; PRIORITY JOURNAL; PROTEIN ANALYSIS; SKIN BIOPSY; VASCULITIS;

EID: 58049195584     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/0003-4819-149-12-200812160-00019     Document Type: Letter

References (5)

1. Gumber SC, Chopra S. Hepatitis C: a multifaceted disease. Review of extrahepatic manifestations. Ann Intern Med. 1995;123:615-20. [PMID: 7677303]
2. Sawabe T, Uenotsuchi T, Imafuku S, Kohno H, Arima J, Horiuchi T. Remission of hepatitis B virus-related vasculitis with lamivudine [Letter]. Ann Intern Med. 2004;140:672-3. [PMID: 15096355]
3. Stecevic V, Pevzner MM, Gordon SC. Successful treatment of hepatitis B-associated vasculitis with lamivudine [Letter]. J Clin Gastroenterol. 2003;36:451. [PMID: 12702993]
4. Çakir N, Pamuk ON, Umit H, Midilli K. Successful treatment with adefovir of one patient whose cryoglobulinemic vasculitis relapsed under lamivudine therapy and who was diagnosed to have HBV virologic breakthrough with YMDD mutations. Intern Med. 2006;45:1213-5. [PMID: 17139120]
5. Chang TT, Gish RG, de Man R, Gadano A, Sollano J, Chao YC, et al. BEHoLD AI463022 Study Group. A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B. N Engl J Med. 2006;354:1001-10. [PMID: 16525137]